Q4
LONG ANSWER
10M
★ High-yield
Describe the tumours of the uveal tract.
Choroidal Melanoma
- Uveal melanoma is the commonest primary intraocular malignancy of adults (as retinoblastoma is of children); 90% arise in the choroid, and the remainder in the ciliary body and iris
- Risk factors — fair skin and light iris; oculodermal melanocytosis (naevus of Ota); the BAP1 tumour predisposition syndrome; dysplastic naevus syndrome; and increasing age. It is rare in dark-skinned populations, and therefore much less common in India than in Europe
- Presentation — frequently asymptomatic and found incidentally; otherwise blurred vision, field loss, floaters or photopsia; and rarely pain from secondary glaucoma or necrosis
| Feature | Description |
|---|---|
| Shape | A dome-shaped pigmented or amelanotic mass; and where the tumour ruptures BRUCH’S membrane it assumes the classical collar-stud or mushroom shape. |
| Orange pigment | Lipofuscin over the tumour surface — an important sign of activity and a risk factor for growth |
| Subretinal fluid | An exudative detachment, often shifting with posture |
| Ultrasound (A-scan) | Low to medium internal reflectivity — characteristic, and distinguishing it from a haemangioma (high reflectivity) or metastasis |
| Ultrasound (B-scan) | An acoustically hollow mass with choroidal excavation and orbital shadowing |
| The "TFSOM" risk factors |
|
Other Uveal Tumours
| Tumour | Features |
|---|---|
| Choroidal naevus |
|
| Choroidal metastasis |
|
| Choroidal haemangioma |
|
| Iris lesions | Iris naevus — flat and stable; iris melanoma — raised, over 3 mm, with prominent vessels, ectropion uveae, sectoral cataract, and seeding into the angle with raised pressure; and LISCH nodules — multiple bilateral tan hamartomas which are pathognomonic of neurofibromatosis type 1 |
| Melanocytoma | A deeply pigmented, benign tumour characteristically at the optic disc, commoner in dark-skinned individuals; benign but requires monitoring for rare malignant transformation |
Choroidal Naevus Compared with Melanoma
| Feature | Naevus (benign) | Melanoma |
|---|---|---|
| Thickness | Less than 2 mm | Greater than 2 mm |
| Diameter | Usually under 5 mm | Larger, and growing |
| Subretinal fluid | Absent | Present |
| Orange pigment (lipofuscin) | Absent | Present |
| Overlying drusen | Present — a sign of chronicity and reassuring | Usually absent |
| Symptoms | None — found incidentally | Blurring, field loss, photopsia |
| Margin to the optic disc | Any distance | Within 3 mm is a risk factor |
| A-scan reflectivity | High or medium | Low to medium; acoustically hollow with choroidal excavation |
| Management | Photograph and observe | Brachytherapy, proton beam or enucleation; and lifelong liver surveillance |
Applied Aspects
- Apply the TFSOM criteria to every pigmented choroidal lesion; thickness, fluid, symptoms, orange pigment and proximity to the disc distinguish a naevus to watch from a melanoma to treat
- Look for drusen over the lesion; they indicate a long-standing benign naevus and are reassuring
- Get an A-scan; low internal reflectivity supports melanoma and high reflectivity supports haemangioma or metastasis, and it costs nothing
All questions in Diseases of the Uveal Tract
- Q1Describe the anatomy of the uveal tract. Classify uveitis and describe anterior uveitis with its management. ★
- Q2Describe intermediate and posterior uveitis with their causes and investigation. ★
- Q3Describe the complications of uveitis and the principles of its management. ★
- Q4Describe the tumours of the uveal tract. ★
- Q5Describe endophthalmitis and panophthalmitis with their management. ★
- SN1Describe sympathetic ophthalmitis with its prevention and treatment. ★
- SN2Describe keratic precipitates and the other signs of uveitis. ★
- SN3Describe ocular tuberculosis and sarcoidosis. ★
- SN4Describe ocular toxoplasmosis with its features and management. ★
- SN5Describe Vogt-Koyanagi-Harada disease and the other specific uveitic syndromes. ★
- SN6Describe uveal coloboma and the congenital anomalies of the iris. ★
- SN7Describe HLA-B27 associated uveitis and uveitis in the immunosuppressed.